TSHA
Taysha Gene Therapies Inc
4.40$
+0.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.8% | 86.8% | 85.4% | 89.1% | 89.6% | 88.6% | 87.2% | 94.9% | 94.8% | 94.6% | 94.0% | 98.1% | |
| 83.9% | 83.3% | 81.0% | 86.2% | 87.5% | 86.7% | 84.3% | 93.8% | 93.9% | 93.1% | 92.1% | 96.8% | |
| 83.9% | 83.3% | 81.0% | 86.2% | 87.5% | 86.7% | 84.3% | 93.8% | 93.9% | 93.1% | 92.1% | 96.8% | |
| 125.1% | 56.6% | 64.8% | 45.7% | 50.7% | 55.4% | 60.2% | 25.4% | 30.8% | 28.1% | 29.4% | 17.7% | |
| 92.2% | 21.3% | 25.3% | 17.1% | 16.3% | 16.4% | 16.3% | 7.6% | 9.0% | 7.7% | 6.7% | 5.5% | |
| 0.8% | 1.0% | 1.1% | 0.9% | 1.0% | 1.2% | 1.3% | 0.5% | 0.5% | – | – | – | |
| 3.8% | 3.7% | 6.8% | 4.4% | 2.7% | 2.2% | 3.1% | 2.3% | 1.7% | 1.8% | 1.5% | 1.9% | |
| 19.7% | 23.5% | 26.5% | 18.9% | 23.8% | 27.4% | 30.7% | 12.3% | 16.1% | 14.6% | 16.3% | 10.5% | |
| -25.1% | 43.4% | 35.2% | 54.3% | 49.3% | 44.6% | 39.8% | 74.6% | 69.2% | 71.9% | 70.6% | 82.3% | |
| -286.4% | -297.0% | -351.0% | -278.5% | -323.8% | -375.6% | -450.9% | -195.2% | -215.9% | -207.2% | -250.9% | -170.1% | |
| 64.2% | 108.2% | 151.1% | 116.2% | 148.6% | 127.8% | 194.6% | 89.4% | 111.6% | 93.1% | 122.1% | 78.4% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.